156 related articles for article (PubMed ID: 22677656)
1. Screening of new huprines--inhibitors of acetylcholinesterases by electrospray ionization ion trap mass spectrometry.
Ziemianin A; Ronco C; Dolé R; Jean L; Renard PY; Lange CM
J Pharm Biomed Anal; 2012 Nov; 70():1-5. PubMed ID: 22677656
[TBL] [Abstract][Full Text] [Related]
2. New huprine derivatives functionalized at position 9 as highly potent acetylcholinesterase inhibitors.
Ronco C; Foucault R; Gillon E; Bohn P; Nachon F; Jean L; Renard PY
ChemMedChem; 2011 May; 6(5):876-88. PubMed ID: 21344648
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids.
Alcalá Mdel M; Vivas NM; Hospital S; Camps P; Muñoz-Torrero D; Badia A
Neuropharmacology; 2003 May; 44(6):749-55. PubMed ID: 12681373
[TBL] [Abstract][Full Text] [Related]
4. Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease.
Camps P; Cusack B; Mallender WD; El Achab RE; Morral J; Muñoz-Torrero D; Rosenberry TL
Mol Pharmacol; 2000 Feb; 57(2):409-17. PubMed ID: 10648652
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology of novel acetylcholinesterase inhibitors, (+/-)-huprines Y and X, on the Torpedo electric organ.
Ros E; Aleu J; Gómez de Aranda I; Muñoz-Torrero D; Camps P; Badia A; Marsal J; Solsona C
Eur J Pharmacol; 2001 Jun; 421(2):77-84. PubMed ID: 11399262
[TBL] [Abstract][Full Text] [Related]
6. Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
Pérez-Areales FJ; Di Pietro O; Espargaró A; Vallverdú-Queralt A; Galdeano C; Ragusa IM; Viayna E; Guillou C; Clos MV; Pérez B; Sabaté R; Lamuela-Raventós RM; Luque FJ; Muñoz-Torrero D
Bioorg Med Chem; 2014 Oct; 22(19):5298-307. PubMed ID: 25156301
[TBL] [Abstract][Full Text] [Related]
7. Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy.
Mezeiova E; Korabecny J; Sepsova V; Hrabinova M; Jost P; Muckova L; Kucera T; Dolezal R; Misik J; Spilovska K; Pham NL; Pokrievkova L; Roh J; Jun D; Soukup O; Kaping D; Kuca K
Molecules; 2017 Jul; 22(8):. PubMed ID: 28788095
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of Huprine derivatives as human acetylcholinesterase inhibitors.
Ronco C; Sorin G; Nachon F; Foucault R; Jean L; Romieu A; Renard PY
Bioorg Med Chem; 2009 Jul; 17(13):4523-36. PubMed ID: 19473849
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein-huprine hybrids.
Pérez-Areales FJ; Betari N; Viayna A; Pont C; Espargaró A; Bartolini M; De Simone A; Rinaldi Alvarenga JF; Pérez B; Sabate R; Lamuela-Raventós RM; Andrisano V; Luque FJ; Muñoz-Torrero D
Future Med Chem; 2017 Jun; 9(10):965-981. PubMed ID: 28632395
[TBL] [Abstract][Full Text] [Related]
10. 3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates.
Dvir H; Wong DM; Harel M; Barril X; Orozco M; Luque FJ; Muñoz-Torrero D; Camps P; Rosenberry TL; Silman I; Sussman JL
Biochemistry; 2002 Mar; 41(9):2970-81. PubMed ID: 11863435
[TBL] [Abstract][Full Text] [Related]
11. Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis.
Galdeano C; Coquelle N; Cieslikiewicz-Bouet M; Bartolini M; Pérez B; Clos MV; Silman I; Jean L; Colletier JP; Renard PY; Muñoz-Torrero D
Molecules; 2018 Mar; 23(3):. PubMed ID: 29534488
[TBL] [Abstract][Full Text] [Related]
12. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
Zhang S; Hou B; Yang H; Zuo Z
Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
[TBL] [Abstract][Full Text] [Related]
13. Huprine Y - Tryptophan heterodimers with potential implication to Alzheimer's disease treatment.
Mezeiova E; Hrabinova M; Hepnarova V; Jun D; Janockova J; Muckova L; Prchal L; Kristofikova Z; Kucera T; Gorecki L; Chalupova K; Kunes J; Hroudova J; Soukup O; Korabecny J
Bioorg Med Chem Lett; 2021 Jul; 43():128100. PubMed ID: 33984470
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors.
Camps P; Formosa X; Muñoz-Torrero D; Petrignet J; Badia A; Clos MV
J Med Chem; 2005 Mar; 48(6):1701-4. PubMed ID: 15771413
[TBL] [Abstract][Full Text] [Related]
15. Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates.
Viayna E; Gómez T; Galdeano C; Ramírez L; Ratia M; Badia A; Clos MV; Verdaguer E; Junyent F; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Camps P; Muñoz-Torrero D
ChemMedChem; 2010 Nov; 5(11):1855-70. PubMed ID: 20859987
[TBL] [Abstract][Full Text] [Related]
16. Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.
Galdeano C; Viayna E; Sola I; Formosa X; Camps P; Badia A; Clos MV; Relat J; Ratia M; Bartolini M; Mancini F; Andrisano V; Salmona M; Minguillón C; González-Muñoz GC; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Muñoz-Torrero D
J Med Chem; 2012 Jan; 55(2):661-9. PubMed ID: 22185619
[TBL] [Abstract][Full Text] [Related]
17. Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain.
Roman S; Vivas NM; Badia A; Clos MV
Neurosci Lett; 2002 Jun; 325(2):103-6. PubMed ID: 12044632
[TBL] [Abstract][Full Text] [Related]
18. Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes.
Roman S; Badia A; Camps P; Clos MV
Neuropharmacology; 2004 Jan; 46(1):95-102. PubMed ID: 14654101
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and discovery of novel hexacyclic cage compounds as inhibitors of acetylcholinesterase.
Suresh Kumar R; Ashraf Ali M; Osman H; Ismail R; Choon TS; Yoon YK; Wei AC; Pandian S; Manogaran E
Bioorg Med Chem Lett; 2011 Jul; 21(13):3997-4000. PubMed ID: 21621414
[TBL] [Abstract][Full Text] [Related]
20. Huprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: from rational design to validation by X-ray crystallography.
Ronco C; Carletti E; Colletier JP; Weik M; Nachon F; Jean L; Renard PY
ChemMedChem; 2012 Mar; 7(3):400-5. PubMed ID: 22052791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
